EXEC COVID-19 News
Investigation of EU COVID-19 Vaccine Contracts
2021 23 Jan
The European Ombudsman is investigating the European Commission’s refusal to give public access to documents concerning the purchase of vaccines against COVID-19. You might also like: COVID-19 Vaccine: From Ethics of Early Access to Payments for Risk After receiving two complaints, the Ombudsman office has opened an... Read more
New Vaccine Agreements for COVAX
2021 23 Jan
COVAX, the global initiative to ensure equitable access to COVID-19 vaccines across the world, has announced new agreements for Pfizer/BioNTech and AstraZeneca/Oxford vaccines delivery, about 200 million doses in total. You might also like: COVID-19 Vaccines: Tracking and Future Distribution Specifically,... Read more
Close Circle Affects Behaviour During Pandemic
2021 22 Jan
Social influences are more important for people’s adherence to distancing rules during the pandemic than their own beliefs, a new study shows ( Tunçgenç et al. 2021) . You might also like: Communicating COVID-19 Uncertainty to Public The pandemic has demanded a drastic change in our behaviours, with social distancing being... Read more
Securing Trust In The Global COVID-19 Supply Chain
2021 28 Jan
Find GS1 Ireland on Social Media Read more
EU: 70% Vaccinated by Summer
2021 20 Jan
The European Commission has called member states to accelerate the roll-out of their vaccination programmes. The aim is to have vaccinated 70% of the adult population by summer 2021. You might also like: EU Reports on State of Health In a new communication , the Commission identifies some key actions needed... Read more
WHO-led Discussion on COVID-19 Vaccines
2021 16 Jan
Under the umbrella of the World Health Organization, its Emergency Committee and several thousands of scientists looked into the challenges related to COVID-19 vaccine safety, efficacy and access. You might also like: COVID-19 Vaccine: From Ethics of Early Access to Payments for Risk T he meeting of the Emergency Committee... Read more
PHE Study: Immunity in COVID-19 Survivors
2021 15 Jan
According to SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study being conducted by Public Health England (PHE), those who were previously infected with COVID-19 are likely to be immune against the disease for several months, although they still could infect others. You might also like: COVID-19: Immunity-Based Strategies... Read more
Nurse's View: Are We Back to Square One with COVID-19 in UK?
2021 11 Jan
A personal reflection from a COVID-recovered Staff Nurse. Happy New Year! I should scream it from the bottom of my heart to you all, dear readers, but it is only early January and I don’t feel really happy. It is THE NEW YEAR, but my feelings say – it is still March 2020 onwards, when the horror of COVID-19 started in the UK.... Read more
Communicating COVID-19 Uncertainty to Public
2020 17 Dec
A group of researchers from Germany has looked into the challenges of communication between healthcare sector and the wider public about COVID-19. The study specifically focused on various approaches to communicating the uncertainty surrounding the pandemic. You might also like: COVID-19: Immunity-Based Strategies are ‘Flawed’ ... Read more
Nurse’s View: How Do I Feel About COVID-19 Vaccine?
2020 17 Dec
Inaugurating her new column with HealthManagement.org, Sabine Torgler reflects on the news about the start of the vaccination programme against COVID-19 in the UK from the nurse’s perspective. Since two weeks ago, it is public that the UK is starting its vaccination programme against COVID-19. When the BBC reported it on Wednesday,... Read more
COVID-19 Infection at Work: Who is at Risk?
2020 12 Dec
Essential workers, especially those in healthcare, have a greater risk of COVID-19 due to the nature of their work. Aside from healthcare workers (HWCs), however, not much is known as to which other occupational groups are most at risk for infection. You might also like: How Exposure to SARS-CoV-2 Varies Across Hospital Settings... Read more
EU Reports on State of Health
2020 10 Dec
With the COVID-19 pandemic currently being the main factor to be considered in the health and well-being assessments, other elements, such as quality of air, smoking and alcohol consumption, and obesity also contribute to the state of health of European populations, says a new report from the European Commission. You might also like:... Read more
Pandemic Control: New Dynamic Metrics for Proactive Action
2020 08 Dec
Without a national and coordinated response to COVID-19, the United States has been ineffective at preventing and mitigating the escalating pandemic. What the country needs, according to new research ( Post et al. 2020) , is a dynamic public health surveillance to better inform prevention efforts. You might also like: COVID-19: Immunity-Based... Read more
Major Moves with COVID-19 Vaccines
2020 02 Dec
The UK, first in the world, authorises Pfizer COVID-19 vaccine and is looking into fast-tracking AstraZeneca’s. In the meantime, Pfizer and Moderna both file applications for their vaccines’ emergency use in the U.S. and Europe. You might also like: Coronavirus, Tensegrity and CSR: Year of Living Dangerously The... Read more
Global Solidarity on #WorldAIDSDay
2020 01 Dec
Since 1988, each year on 1 December World AIDS Day is observed raising awareness of the ongoing AIDS pandemic and mourning those who have died of the disease. You might also like: Zoom On: Françoise Barré-Sinoussi, International AIDS Society President While for now the focus of the international community may be on the... Read more
Clinical Education During COVID-19
2020 25 Nov
The pandemic has changed the way care is delivered, with clinical staff fighting an unknown disease, others being assigned to previously unfamiliar areas, and medical students being involved as workforce. To adapt, clinical educators must change their ways of working and develop new methods of training delivery. The clinical education team at... Read more
Milestone for COVID-19 Vaccine
2020 18 Nov
Pfizer has completed the Phase 3 of its COVID-19 vaccine trial and is ready to seek authorisation for emergency use in the U.S. The vaccine is reported to be 95% effective. Two other vaccine candidates, those of Moderna and the Russian Gamaleya Research Institute, demonstrated 94.5% and 92% efficacy, respectively, but the trials are still... Read more
Democracy Against COVID-19
2020 18 Nov
A new analysis provides insights into how democratic institutions play a significant role in the way countries mount quick policy response to existential threats, such as the COVID-19 pandemic (Shvetsova et al. 2020). You might also like: Global COVID-19 Response: “A Collective Failure” When institutional systems... Read more
Future Threats of Anti-COVID-19 Measures
2020 12 Nov
Non-pharmaceutical interventions (NPIs) – social distancing, use of face masks, school closures, etc. – help control COVID-19 transmission. NPIs also reduce the spread of other endemic diseases such as influenza and respiratory syncytial virus (RSV), disrupting the "seasonal transmission patterns" of these other respiratory diseases. ... Read more
COVID-19 Vaccine: From Ethics of Early Access to Payments for Risk
2020 11 Nov
Promising results from ongoing trials have raised hopes that the first vaccines against COVID-19 could be approved for use in the beginning of 2021. However, as vaccine doses available initially will not be sufficient for every one willing to get vaccinated, prioritisation becomes imperative. On the other hand, when a vaccine is widely available, should... Read more